Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66755-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- TRAF4 antibody
- Antibody type
- Monoclonal
- Description
- TRAF4 antibody (Cat. #66755-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, pig and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2C9A11
- Vial size
- 20ul, 150ul
Submitted references TRAF4-Mediated LAMTOR1 Ubiquitination Promotes mTORC1 Activation and Inhibits the Inflammation-Induced Colorectal Cancer Progression.
TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway.
High expression of TRAF4 predicts poor prognosis in tamoxifen-treated breast cancer and promotes tamoxifen resistance.
Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Zhao L, Gao N, Peng X, Chen L, Meng T, Jiang C, Jin J, Zhang J, Duan Q, Tian H, Weng L, Wang X, Tan X, Li Y, Qin H, Yuan J, Ge X, Deng L, Wang P
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Mar;11(12):e2301164
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Mar;11(12):e2301164
TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway.
Gu H, Zhu S, Peng C, Wei Z, Shen Y, Yuan C, Yang H, Cui H, Yang L
International journal of molecular sciences 2022 Sep 5;23(17)
International journal of molecular sciences 2022 Sep 5;23(17)
High expression of TRAF4 predicts poor prognosis in tamoxifen-treated breast cancer and promotes tamoxifen resistance.
Zhou J, Li W, Ming J, Yang W, Lu L, Zhang Q, Ruan S, Huang T
Anti-cancer drugs 2020 Jul;31(6):558-566
Anti-cancer drugs 2020 Jul;31(6):558-566
Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Peng P, Chen T, Wang Q, Zhang Y, Zheng F, Huang S, Tang Y, Yang C, Ding W, Ren D, Huang Z, Guo Y
Oncology research and treatment 2019;42(4):165-185
Oncology research and treatment 2019;42(4):165-185
No comments: Submit comment
No validations: Submit validation data